KIR3DL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Dasatinib promoted NK-cell cytokine expression and cytotoxic activity towards the CML-derived cell line K562 [18,40], especially when KIR3DL1/HLA-Bw4 interactions were null, low or weak.